Classification and molecular mechanism of action
Potassium-sparing diuretics are divided into two main subgroups that operate in the same nephron segments but have completely different points of action at the cellular level.
- Sodium channel blockers (Triamterene, Amiloride). These drugs act as direct blockers. They physically close the epithelial sodium channels (ENaC) located on the apical membrane of the cells. As a result, sodium cannot enter the cell and is excreted in the urine.
- Mineralocorticoid receptor antagonists (Spironolactone, Eplerenone). They are competitive antagonists of aldosterone and deoxycorticosterone receptors. Their site of action is intracellular receptors. Normally, the hormone aldosterone stimulates the synthesis of proteins for new ENaC and $Na^+/K^+$-ATPase, which enhances sodium reabsorption and potassium secretion. Drugs in this group exert the exact opposite effect. They bind to the receptor, block it, and disrupt the synthesis of new channels. Membrane permeability to sodium decreases.
The net effect of both groups is the same: a decrease in sodium reabsorption (it is excreted, drawing corresponding volumes of water along with it) and a decrease in potassium secretion (potassium-sparing effect).
Pharmacokinetics and diuretic effect features
The efficacy of potassium-sparing diuretics is considered quite moderate. At the same time, drugs affecting intracellular receptors have pronounced temporal characteristics.
For example, the diuretic effect of Spironolactone (trade names: Aldactone, Veroshpiron) develops very slowly. The latent period ranges from 2 to 5 days from the start of therapy. This delay is due to the drug's pharmacokinetics and the fact that target cells require time to adjust their protein synthesis. Notably, after discontinuing the drug, its aftereffect persists for several more days.
Dosing regimen:
- It is recommended to take the drugs in divided doses.
- It is preferable to take them on an empty stomach.
- Administration should be carried out strictly in the first half of the day to avoid nocturnal diuresis and disruption of the patient's sleep.
Clinical application and combination therapy
The main strategy for using these drugs is combination therapy. It is rational to prescribe them together with potassium-losing diuretics (loop or thiazide diuretics). A classic example of such a combination is hydrochlorothiazide + triamterene. This effectively corrects blood potassium levels.
Independent and specific indications for prescription:
- Edematous syndrome pathogenetically associated with an excess of mineralocorticoids (aldosterone). This includes primary and secondary hyperaldosteronism, including in the setting of chronic heart failure and liver cirrhosis.
- Essential hypertension.
- Liddle syndrome. This is a rare hereditary form of arterial hypertension whose pathogenesis is based on an ENaC mutation leading to their hyperactivity. The drugs of choice in this case are direct sodium channel blockers.
Regulatory status note: the drug Amiloride is currently excluded from the state register of medicines in the Russian Federation.
Safety profile and adverse effects
Despite their moderate diuretic effect, these drugs have a number of significant adverse effects that require monitoring:
- Electrolyte imbalances: this is the primary risk with prolonged use. Ion retention leads to the development of hyperkalemia.
- Systemic and allergic reactions: hypotension (excessive drop in blood pressure) and skin rashes may occur.
- Dyspeptic disorders: patients may complain of nausea, vomiting, and diarrhea.
- Endocrine disorders: specific to Spironolactone. Because the drug has a steroid structure, it can affect sex hormones. In men, this can manifest as impotence and gynecomastia, and in women, as menstrual irregularities.
To avoid confusing the sites of action: direct blockers (amiloride, triamterene) work from the outside, closing channels on the apical membrane, while spironolactone acts covertly—inside the cell, blocking receptors.
Class and exam questions
Why does spironolactone start working only after a few days?
Its effect depends on the response speed of target cells. The drug blocks intracellular receptors, disrupting the synthesis of new sodium channels, and such a protein metabolism adjustment takes from 2 to 5 days.
Why are potassium-sparing diuretics prescribed together with hydrochlorothiazide or furosemide?
Thiazide and loop diuretics actively excrete potassium, causing hypokalemia. The addition of potassium-sparing drugs (e.g., triamterene) helps correct the electrolyte balance.
What specific adverse effects does spironolactone have?
Due to its steroid structure, it affects sex hormones. This can cause gynecomastia and impotence in men, as well as menstrual irregularities in women.
What is Liddle syndrome and how is it treated?
This is a rare hereditary form of arterial hypertension caused by a mutation and hyperactivity of ENaC channels. The drugs of choice for it are direct sodium channel blockers.
What else to study on this topic
- Pathogenesis of Liddle syndrome and epithelial sodium channel (ENaC) mutations
- Primary and secondary hyperaldosteronism: differential diagnostics
- Pharmacokinetics of spironolactone and reasons for prolonged aftereffect
- Comparative characteristics of spironolactone and eplerenone
- Mechanisms of endocrine disorders development during spironolactone therapy
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Potassium-sparing diuretics" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Diuretics"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.